TrialBMC cardiovascular disorders2023

Efficacy and safety analysis of angiotensin receptor neprilysin inhibition(ARNI)in patients with heart failure: a real-world retrospective study.

Xiaobo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.